Healthcare and Life Sciences Research Reports provide valuable insights into the dynamic and rapidly evolving healthcare and life sciences sectors. These reports cover various aspects of healthcare, including pharmaceuticals, biotechnology, medical devices, healthcare services, and more
The global anosmia market size was valued at USD 2,700 million in 2021 and is projected to reach around USD 4,500 million in 2030 exhibiting a CAGR of 7.0% in the forecasted period. The growing incidence of anosmia and increasing research activities by the market players & research organizations are...
In 2021, the market for Intubation Tubes worldwide was worth $ 2.0 billion US dollars. AMR Group projects that the market will reach US$ 4.16 billion by 2031, growing at a CAGR of 6.8 percent between 2022 and 2031.Industry OverviewIntubation Tubes are a catheter used to establish and maintain an air...
In 2022, the market for Independent Diagnostic Testing Facility worldwide was worth $160 billion US dollars. AMR Group projects that the market will reach US$ 345 billion by 2031, growing at a CAGR of 8.2 percent between 2023 and 2031.Industry OverviewIndependent Diagnostic Testing Facility is used ...
In 2021, the market for Hemodialysis and Peritoneal Dialysis worldwide was worth $ 17 billion US dollars. AMR Group projects that the market will reach US$ 24 billion by 2031, growing at a CAGR of 6.3 percent between 2022 and 2031.Industry OverviewHemodialysis is a method of treatment for people wit...
In 2021, the market for Foot Ulcer Sensors worldwide was worth $ 9.20 billion US dollars. AMR Group projects that the market will reach US$ 15.3 billion by 2031, growing at a CAGR of 6.5 percent between 2022 and 2031.Industry OverviewPatients who have lost their sense of protective sensation, such a...
In 2021, the market for Artificial Corneal Implants worldwide was worth $ 410 million US dollars. AMR Group projects that the market will reach US$ 697 million by 2031, growing at a CAGR of 6.2 percent between 2022 and 2031.Industry OverviewArtificial Corneal Implants are the artificially made by us...
The global xerostomia therapeutics market size was valued at USD 650 million in 2021 and is projected to reach around USD 950 million in 2030 exhibiting a CAGR of 3.5% in the forecasted period. The rising adoption of chemotherapy and radiotherapy in cancer treatment coupled with increasing use of pr...
The global urea cycle disorders treatment market size was valued at USD 1,250 million in 2021 and is projected to reach around USD 1,650 million in 2030 exhibiting a CAGR of 3.5% in the forecasted period. The increasing prevalence of urea cycle disorders and the growing number of pipeline products. ...
The global severe acute respiratory syndrome (SARS) treatment market size was valued at USD 25.7 billion in 2021 and is projected to reach around USD 8.2 billion in 2030 exhibiting a CAGR of 14.5% in the forecasted period. The rising cases of COVID-19, increase in the number of numerous contagious d...
The global relapsed or refractory diffuse large B-cell lymphoma market size was valued at USD 1,500 million in 2021 and is projected to reach around USD 2,200 million in 2030 exhibiting a CAGR of 4.2% in the forecasted period. The rise in the number of oncology procedures is anticipated to boost the...
The global pulmonary edema therapeutics market size was valued at USD 150 million in 2021 and is projected to reach around USD 550 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The rising incidence of heart failure, a major cause of pulmonary edema, an increasing geriatric popu...
The global Prurigo nodularis treatment market size was valued at USD 820 million in 2021 and is projected to reach around USD 1,200 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The rising pharmaceutical & biotechnology industry and growing focus on orphan drug development are ...
The global progressive familial intrahepatic cholestasis type 2 treatment market size was valued at USD 35 million in 2021 and is projected to reach around USD 550 million in 2030 exhibiting a CAGR of 39.0% in the forecasted period. The rise in the number of drug approvals from the regulatory bodies...
The global hypertension in CKD market size was valued at USD 210 million in 2021 and is projected to reach around USD 450 million in 2030 exhibiting a CAGR of 10.6% in the forecasted period. The growing dominance of dialysis and diuretic therapies in hypertension patients to decrease blood volume in...
The global agitation in delirium management market size was valued at USD 220 million in 2021 and is projected to reach around USD 350 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The upsurge in the prevalence of delirium, growing geriatric population, increasing government in...
The global cholangiocarcinoma market size was valued at USD 185 million in 2021 and is projected to reach around USD 450 million in 2030 exhibiting a CAGR of 12.5% in the forecasted period. The high expenditure on the healthcare sector by the management and the customers boosts the market growth. In...
In 2021, the market for Biological Skin Substitutes worldwide was worth $0.71 billion US dollars. AMR Group projects that the market will reach US$ 1.34 billion by 2031, growing at a CAGR of 5.2 percent between 2022 and 2031.Industry OverviewBiological Skin Substitutes are organic, synthetic, or met...
The global sciatica market size was valued at USD 6,000 million in 2021 and is projected to reach around USD 9,200 million in 2030 exhibiting a CAGR of 4.8% in the forecasted period. The increasing awareness about sciatica, increasing incidence and prevalence of sciatica, strong pipeline of products...
The global rapid self-healing gel market size was valued at USD 250 million in 2021 and is projected to reach around USD 500 million in 2030 exhibiting a CAGR of 8.0% in the forecasted period. The rise in trauma and chronic wound conditions, growth in the clinical trials are shown to augment the eff...
The global psoriatic arthritis treatment market size was valued at USD 8,700 million in 2021 and is projected to reach around USD 21,500 million in 2030 exhibiting a CAGR of 11.5% in the forecasted period. Upsurge in biological and biosimilar treatments, growth in incidence of psoriatic arthritis, d...
The global polycythemia Vera therapeutics market size was valued at USD 1,500 million in 2021 and is projected to reach around USD 2,200 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The rising incidence of polycythemia Vera, growing approval of new products, and boosting colla...
The global opioid use disorder market size was valued at USD 2,700 million in 2021 and is projected to reach around USD 5,200 million in 2030 exhibiting a CAGR of 8.5% in the forecasted period. The growth in the opioid epidemic in the U.S. along with the formation of government policies to regulate ...
The global genital warts treatment market size was valued at USD 1,600 million in 2021 and is projected to reach around USD 2,500 million in 2030 exhibiting a CAGR of 4.5% in the forecasted period. The rise in prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections and...
The global fungal otitis externa market size was valued at USD 170 million in 2021 and is projected to reach around USD 220 million in 2030 exhibiting a CAGR of 3.0% in the forecasted period. The rising development and sanction of latest therapies for the management of fungal otitis externa, growing...
The global eczema therapeutics market size was valued at USD 15,000 million in 2021 and is projected to reach around USD 35,000 million in 2030 exhibiting a CAGR of 11% in the forecasted period. The rising prevalence of atopic dermatitis is anticipated to upsurge the market growth. Additionally, fav...